Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Oracle
ORCL
|
+$881M |
| 2 |
DoorDash
DASH
|
+$403M |
| 3 |
Amgen
AMGN
|
+$403M |
| 4 |
Amazon
AMZN
|
+$282M |
| 5 |
Applied Materials
AMAT
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Abbott
ABT
|
+$592M |
| 2 |
Workday
WDAY
|
+$580M |
| 3 |
United Parcel Service
UPS
|
+$468M |
| 4 |
Apple
AAPL
|
+$438M |
| 5 |
Atlassian
TEAM
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.97% |
| 2 | Healthcare | 19.05% |
| 3 | Consumer Discretionary | 10.13% |
| 4 | Financials | 9.7% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2126
Essential Utilities
WTRG
$11.4B
| $380K | ﹤0.01% |
10,264
-17,034
| -62% | -$618K |
|
2127
Vir Biotechnology
VIR
$1.5B
| $380K | ﹤0.01% |
37,513
+5
| +0% | +$51 |
|
2128
Skywest
SKYW
$4.29B
| $379K | ﹤0.01% |
5,487
| – | – |
|
2129
Ameresco
AMRC
$1.09B
| $379K | ﹤0.01% |
15,717
-39,567
| -72% | -$887K |
|
2130
Toro Company
TTC
$8.72B
| $379K | ﹤0.01% |
4,135
-33,956
| -89% | -$3.13M |
|
2131
Vicor
VICR
$9.42B
| $377K | ﹤0.01% |
9,857
+1
| +0% | +$39 |
|
2132
ProFrac Holding
ACDC
$671M
| $377K | ﹤0.01% |
45,039
-22,842
| -34% | -$175K |
|
2133
Marcus & Millichap
MMI
$1.18B
| $376K | ﹤0.01% |
11,003
| – | – |
|
|
HAPN
2134
Happen Inc
HAPN
$2.23B
| $374K | ﹤0.01% |
42,574
+2
| +0% | +$17 |
|
2135
Kelly Services Class A
KELYA
$521M
| $373K | ﹤0.01% |
14,890
+1
| +0% | +$22 |
|
2136
HCI Group
HCI
$2.32B
| $371K | ﹤0.01% |
3,206
+6
| +0.2% | +$589 |
|
2137
Symbotic
SYM
$5.46B
| $371K | ﹤0.01% |
8,249
+18
| +0.2% | +$789 |
|
|
DCH
2138
Dauch Corp
DCH
$1.39B
| $370K | ﹤0.01% |
50,347
+2
| +0% | +$15 |
|
2139
Nabors Industries
NBR
$1.22B
| $370K | ﹤0.01% |
4,299
| – | – |
|
2140
Independent Bank Corp
IBCP
$787M
| $370K | ﹤0.01% |
14,618
-7,458
| -34% | -$185K |
|
2141
A10 Networks
ATEN
$2.16B
| $370K | ﹤0.01% |
27,035
+2
| +0% | +$27 |
|
|
BRKL
2142
DELISTED
Brookline Bancorp
BRKL
| $370K | ﹤0.01% |
37,177
+2
| +0% | +$20 |
|
2143
BioLife Solutions
BLFS
$1.55B
| $370K | ﹤0.01% |
19,941
+7
| +0% | +$122 |
|
2144
Navitas Semiconductor
NVTS
$2.87B
| $368K | ﹤0.01% |
77,133
-327,609
| -81% | -$1.92M |
|
2145
Shenandoah Telecom
SHEN
$631M
| $368K | ﹤0.01% |
21,133
| – | – |
|
2146
Gorman-Rupp
GRC
$2.13B
| $365K | ﹤0.01% |
9,231
| – | – |
|
2147
Artivion
AORT
$1.34B
| $365K | ﹤0.01% |
17,239
| – | – |
|
|
AGNT
2148
AGNT Inc
AGNT
$641M
| $364K | ﹤0.01% |
35,271
+2
| +0% | +$25 |
|
2149
Unitil
UTL
$980M
| $364K | ﹤0.01% |
6,940
+1
| +0% | +$50 |
|
2150
ANI Pharmaceuticals
ANIP
$1.83B
| $364K | ﹤0.01% |
5,261
+3
| +0.1% | +$181 |
|
Similar funds
Janus Henderson Group's Q1 2024 Portfolio in Review
As of Q1 2024, Janus Henderson Group held 2,613 positions worth $183B, up 9.3% from $168B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Janus Henderson Group's Q1 2024 filing shows 67 new, 1,353 increased, 903 reduced and 85 closed positions. Its largest new stake was CG Oncology: 1,521,432 shares worth $66.8M. The largest sale was Abbott, an estimated $592M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 33% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q1 2024 buy was CG Oncology: 1,521,432 shares worth $66.8M.
- Janus Henderson Group added most to Oracle in Q1 2024, an estimated $881M increase.
- Janus Henderson Group's biggest Q1 2024 reduction was Abbott, cutting an estimated $592M.
- Janus Henderson Group fully exited Immunogen Inc in Q1 2024, selling an estimated $327M.
- Janus Henderson Group's ten largest holdings make up 28% of its $183B portfolio in Q1 2024.
- Janus Henderson Group opened 67 new positions and closed 85 in Q1 2024.
- Janus Henderson Group's portfolio value rose 9.3% quarter-over-quarter to $183B.
Based on Janus Henderson Group's 13F filing for Q1 2024, filed 15 May 2024.